These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32935235)

  • 41. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis.
    Shibata M; Masuda M; Sasahara K; Sasabe H; Sasaki T; Kim S; Takeuchi K; Umehara K; Kashiyama E
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0257120. PubMed ID: 34097484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Super-swelled lyotropic single crystals.
    Kim H; Song Z; Leal C
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10834-10839. PubMed ID: 28973884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
    Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
    Dong YD; Larson I; Hanley T; Boyd BJ
    Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
    Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
    J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
    Alghamdi WA; Al-Shaer MH; Kipiani M; Barbakadze K; Mikiashvili L; Kempker RR; Peloquin CA
    J Antimicrob Chemother; 2021 Mar; 76(4):1019-1024. PubMed ID: 33378452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
    Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Insights into Using Lipid Based Suspensions for 'Brick Dust' Molecules: Case Study of Nilotinib.
    Koehl NJ; Holm R; Kuentz M; Griffin BT
    Pharm Res; 2019 Feb; 36(4):56. PubMed ID: 30796596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small-volume
    Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
    Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.
    Kadhum WR; Hada T; Hijikuro I; Todo H; Sugibayashi K
    J Oleo Sci; 2017; 66(9):939-950. PubMed ID: 28867759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
    Mallikaarjun S; Wells C; Petersen C; Paccaly A; Shoaf SE; Patil S; Geiter L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5976-85. PubMed ID: 27458223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Pharm Sci; 2005 Mar; 94(3):481-92. PubMed ID: 15619248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.